Frequency of Human papillomavirus in women attending cervical cancer screening program in Chile

被引:7
作者
Brebi, Priscilla [1 ,2 ]
Gloria Ili, Carmen [1 ,2 ]
Andana, Alejandra [1 ,2 ]
Menzel, Doris [1 ,2 ]
Lopez, Jaime [1 ,2 ]
Guzman, Pablo [1 ]
Melo, Angelica [2 ]
Buchegger, Kurt [1 ,2 ]
Roa, Juan C. [3 ,4 ]
机构
[1] Univ La Frontera, Fac Med, Dept Anat Patol, Lab Patol Mol, Casilla 54-D, Temuco, Chile
[2] Univ La Frontera, Ctr Excelencia Med Traslac Sci & Technol Bioresou, Casilla 54-D, Temuco, Chile
[3] Pontificia Univ Catolica Chile, Sch Med, Dept Pathol, Marcoleta 377,7th Floor, Santiago, Chile
[4] Millennium Inst Immunol & Immunotherapy P09 016 F, Adv Ctr Chron Dis ACCDiS, Santiago, Chile
关键词
Human papillomavirus; Cervical intraepithelial neoplasia; Cervical cancer; Polymerase chain reaction; Reverse line blotting assay; HYBRID-CAPTURE-II; HPV TYPES; NATURAL-HISTORY; VIRUS; PREVALENCE; LESIONS; IDENTIFICATION; EPIDEMIOLOGY; WORLDWIDE; INFECTION;
D O I
10.1186/s12885-017-3496-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Human papillomavirus (HPV) is the etiological factor for cervical cancer and its precursor lesions. The characterization of HPV genotypes in preneoplastic lesions and cervical cancer could establishes the effectiveness of vaccination plan in Chilean population. The aim of this study was to determine HPV frequency in a group of women including in a cervical screening program in the public health care system in Chile. Methods: We analyzed 985 cervical smears samples from women with different histological diagnosis, attending to public health care in Temuco-Chile between 2004 and 2012, to detect HPV genotypes, through PCR followed by reverse line blotting assay. Results: HPV was found present in 80.8% (n = 796) of samples. Only a 5.6% of 985 samples were infected with a low-risk HPV, considering multiple infections. 10.5% (n = 8/76) of normal cervical epithelia, 83.5% (n = 208/249) and 87.6% (n = 557/636) of low and high grade squamous intraepithelial lesions, respectively, and 95.8% (n = 23/24) of squamous cervical carcinomas tested positive for HPV. HPV 16 was the most frequent genotype found (Overall 44.9%, n = 442/985; SCC: 62.5%, n = 15/24). A high variability of HPV types was also found in preneoplastic lesions, whereas there was a selection of genotypes in neoplasia. Also, there was a higher risk of infection with HPV 16 in women <= 26 years and 34-41 years old (p < 0.05), meanwhile infections with HPV 16 or HPV 18 have related with cancer development (p < 0.01). Conclusions: These data provide further information about the frequency of HPV genotypes in women with cervical lesions in Chile, and the introduction of new targeted vaccines against a wider spectrum of HPV is suggested.
引用
收藏
页数:10
相关论文
共 40 条
  • [1] Aedo S, 2007, REV MED CHILE, V135, P167
  • [2] HPV detection methods
    Brink, Antoinette A. T. P.
    Snijders, Peter J. F.
    Meijer, Chris J. L. M.
    [J]. DISEASE MARKERS, 2007, 23 (04) : 273 - 281
  • [3] The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16-26 Years
    Brown, Darron R.
    Kjaer, Susanne K.
    Sigurdsson, Kristjan
    Iversen, Ole-Erik
    Hernandez-Avila, Mauricio
    Wheeler, Cosette M.
    Perez, Gonzalo
    Koutsky, Laura A.
    Tay, Eng Hseon
    Garcia, Patricia
    Ault, Kevin A.
    Garland, Suzanne M.
    Leodolter, Sepp
    Olsson, Sven-Eric
    Tang, Grace W. K.
    Ferris, Daron G.
    Paavonen, Jorma
    Steben, Marc
    Bosch, F. Xavier
    Dillner, Joakim
    Joura, Elmar A.
    Kurman, Robert J.
    Majewski, Slawomir
    Munoz, Nubia
    Myers, Evan R.
    Villa, Luisa L.
    Taddeo, Frank J.
    Roberts, Christine
    Tadesse, Amha
    Bryan, Janine
    Lupinacci, Lisa C.
    Giacoletti, Katherine E. D.
    Sings, Heather L.
    James, Margaret
    Hesley, Teresa M.
    Barra, Eliav
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (07) : 926 - 935
  • [4] Bruni L, 2019, Summary Report 10 March 2023
  • [5] Human papillomavirus and cervical cancer
    Burd, EM
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2003, 16 (01) : 1 - +
  • [6] HPV genotyping from invasive cervical cancer in Chile
    Carlos Roa, Juan
    Garcia, Patricia
    Gomez, Jorge
    Fernandez, Wanda
    Gaete, Fancy
    Espinoza, Arturo
    Lepetic, Alejandro
    Suarez, Eugenio
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2009, 105 (02) : 150 - 153
  • [7] Molecular interactions of 'high risk' human papillomaviruses E6 and E7 oncoproteins: implications for tumour progression
    Chakrabarti, O
    Krishna, S
    [J]. JOURNAL OF BIOSCIENCES, 2003, 28 (03) : 337 - 348
  • [8] Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis
    Clifford, GM
    Smith, JS
    Aguado, T
    Franceschi, S
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 (01) : 101 - 105
  • [9] Human papillomavirus genotype distribution in low-grade cervical lesions: Comparison by geographic region and with cervical cancer.
    Clifford, GM
    Rana, RK
    Franceschi, S
    Smith, JS
    Gough, G
    Pimenta, JM
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (05) : 1157 - 1164
  • [10] Human papillomavirus types in invasive cervical cancer worldwide:: a meta-analysis
    Clifford, GM
    Smith, JS
    Plummer, M
    Muñoz, N
    Franceschi, S
    [J]. BRITISH JOURNAL OF CANCER, 2003, 88 (01) : 63 - 73